Diltiazem Dosing for Atrial Fibrillation

Initial Treatment

The American College of Cardiology recommends administering diltiazem 0.25 mg/kg IV over 2 minutes for acute rate control in atrial fibrillation with rapid ventricular response, followed by a second bolus of 0.35 mg/kg IV over 2 minutes after 15 minutes if needed, then maintaining with a continuous infusion starting at 10 mg/hour 1, 2
The initial intravenous bolus dosing should be 0.25 mg/kg actual body weight IV over 2 minutes, with a second bolus of 0.35 mg/kg actual body weight IV over 2 minutes after 15 minutes if heart rate reduction is insufficient, as recommended by the American College of Cardiology 1, 3

The American College of Cardiology recommends starting the continuous infusion at 10 mg/hour immediately following the bolus dose once heart rate control is achieved, with titration in 5 mg/hour increments up to a maximum of 15 mg/hour if additional rate control is needed 1, 2, 3
The American College of Cardiology suggests initiating oral diltiazem once stable rate control is maintained for at least 15-30 minutes after IV bolus or during stable continuous infusion, starting with 30-60 mg every 6 hours (120-240 mg/day total) 1, 2

The American College of Cardiology states that diltiazem is contraindicated in heart failure with reduced ejection fraction (LVEF ≤40%) due to negative inotropic effects, pre-excited atrial fibrillation (WPW syndrome with accessory pathway conduction), severe hypotension (systolic BP <90 mmHg), second or third-degree AV block without pacemaker, and decompensated heart failure 2, 3, 4
The American College of Cardiology recommends continuous monitoring of heart rate and blood pressure during bolus administration and for the first 2-4 hours after starting oral therapy, aiming for a target heart rate of <100 bpm at rest or ≥20% reduction from baseline 2

The American College of Cardiology recommends beta-blockers (metoprolol, esmolol, propranolol) as first-line alternatives with Class I recommendation when diltiazem is contraindicated or ineffective, and digoxin for patients with heart failure, with a loading dose of 0.25-0.5 mg IV, then 0.0625-0.25 mg daily maintenance 2, 3
The American College of Cardiology suggests amiodarone for refractory cases or when other agents fail, particularly in heart failure patients 3, 4

Diltiazem provides rate control only and does NOT convert atrial fibrillation to sinus rhythm, with a Class I recommendation with Level of Evidence B for acute rate control, making it one of the most strongly supported agents for this indication 1, 2, 3
The American College of Cardiology recommends using caution when combining diltiazem with beta-blockers due to additive negative chronotropic and inotropic effects, and adjusting the dose in patients with hepatic or renal impairment 1, 2